Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03843775
Title A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity) Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field